Fidelity Investments’s Cardio Diagnostics CDIO Stock Holding History

Fidelity Investments’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3	Closed	-$11	–	5402
2025 Q2	$11	Buy	+3	New	+$22	﹤0.01%	5289

Other funds holding CDIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fidelity Investments's CDIO Position: Q3 2025 in Review

Fidelity Investments sold out of Cardio Diagnostics (CDIO) in Q3 2025, closing a stake of 3 shares — an estimated $11 sold.

Fidelity Investments first reported a position in CDIO in Q2 2025 and held it in 1 quarter. The position peaked at $11 in Q2 2025. 14 funds tracked by Wall St. Rank hold CDIO as of Q3 2025.

Fidelity Investments reported no remaining Cardio Diagnostics position as of Q3 2025 after selling out during the quarter.
Fidelity Investments sold 3 Cardio Diagnostics shares in Q3 2025, an estimated $11.
Fidelity Investments first reported a position in Cardio Diagnostics in Q2 2025 and held it in 1 quarter.
Fidelity Investments's Cardio Diagnostics position peaked at $11 in Q2 2025.
14 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.